Home Newsletters Hepatic Cell News Fibroblast-Derived Prolargin Is a Tumor Suppressor in Hepatocellular Carcinoma

Fibroblast-Derived Prolargin Is a Tumor Suppressor in Hepatocellular Carcinoma

0
Investigators used proteomics and single cell RNA-sequencing analysis to examine the cancer-associated fibroblast landscape in hepatocellular carcinoma.
[Oncogene]
7992332 {7992332:EEEEEEEE} apa 50 1 170796 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
Abstract
Exit mobile version